Hyperledger Global Forum

Bitmark has partnered with big pharma company for a clinical trial matching program that gives researchers a comprehensive data source, an efficient way to track consent and data transfers, & empowers participants to own their health data, via the blockchain. People have remarkable data access rights & are ideal aggregators, but sharing data is extremely hard. Researchers are voracious for data but are limited because of environment, location, & socio-economic factors. People have few incentives to join clinical trials, registries aren’t inclusive, & there’s no way for direct communication with researchers (eg: new side effects). The Bitmark killer app for healthcare hinges on data ownership: individuals can record the daily health data via the Bitmark blockchain, which means they are claiming ownership & establishing property rights. Access control is unlocked when property rights are established—rights to share or sell their data. Now researchers can post the trail they are conducting & be paired with participants for specific types (sleep, location). Consent forms & health data records will be securely shared & tracked. Researchers and participants have direct communication.